Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

Startseite
Investieren
Aktien
USA
USOTC
Calithera Biosciences Inc (CE) (CALA)
Calithera Biosciences Inc (CE) (CALA) News

CALA

Calithera Biosciences (CE) (CALA)

Calithera Biosciences Inc (CE)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CALA

1

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
15/06/2023	15h14	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:CALA	Calithera Biosciences Inc (CE)
05/06/2023	23h17	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	USOTC:CALA	Calithera Biosciences Inc (CE)
26/05/2023	22h29	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	USOTC:CALA	Calithera Biosciences Inc (CE)
26/05/2023	13h09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:CALA	Calithera Biosciences Inc (CE)
26/05/2023	13h09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CALA	Calithera Biosciences Inc (CE)
22/05/2023	12h01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CALA	Calithera Biosciences Inc (CE)
31/03/2023	12h02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h16	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h13	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h10	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h08	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h07	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/03/2023	21h03	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:CALA	Calithera Biosciences Inc (CE)
03/03/2023	16h46	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/02/2023	17h49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CALA	Calithera Biosciences Inc (CE)
14/02/2023	14h04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CALA	Calithera Biosciences Inc (CE)
09/02/2023	22h02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CALA	Calithera Biosciences Inc (CE)
08/02/2023	22h06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CALA	Calithera Biosciences Inc (CE)
07/09/2011	20h00	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	USOTC:CALA	Calithera Biosciences Inc (CE)

Showing the most relevant articles for your search:USOTC:CALA

1

Health Care Select Sector

Deutsche Lufthansa

Deutsche Telekom

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen